Annual ROE
-79.55%
+10.42%+11.58%
31 December 2023
Summary:
Inovio Pharmaceuticals annual return on equity is currently -79.55%, with the most recent change of +10.42% (+11.58%) on 31 December 2023. During the last 3 years, it has fallen by -8.21% (-11.51%). INO annual ROE is now -291.68% below its all-time high of -20.31%, reached on 31 December 2015.INO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-118.17%
-19.45%-19.70%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly return on equity is currently -118.17%, with the most recent change of -19.45% (-19.70%) on 30 September 2024. Over the past year, it has dropped by -35.53% (-42.99%). INO quarterly ROE is now -1376.13% below its all-time high of 9.26%, reached on 31 December 1998.INO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.6% | -43.0% |
| 3 y3 years | -11.5% | -149.0% |
| 5 y5 years | +5.9% | +24.9% |
INO ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -12.8% | +11.6% | -149.0% | at low |
| 5 y | 5 years | -12.8% | +69.2% | -243.8% | +49.7% |
| alltime | all time | -291.7% | +69.2% | -1376.1% | +49.7% |
Inovio Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -118.17%(+19.7%) |
| June 2024 | - | -98.72%(+13.5%) |
| Mar 2024 | - | -86.94%(+8.9%) |
| Dec 2023 | -79.55%(-11.6%) | -79.81%(-3.4%) |
| Sept 2023 | - | -82.64%(+13.4%) |
| June 2023 | - | -72.89%(-19.0%) |
| Mar 2023 | - | -90.00%(-0.8%) |
| Dec 2022 | -89.97%(+27.5%) | -90.76%(-3.2%) |
| Sept 2022 | - | -93.73%(+6.5%) |
| June 2022 | - | -88.03%(+23.3%) |
| Mar 2022 | - | -71.42%(+13.1%) |
| Dec 2021 | -70.55%(-1.1%) | -63.14%(+33.0%) |
| Sept 2021 | - | -47.46%(+38.1%) |
| June 2021 | - | -34.37%(-36.4%) |
| Mar 2021 | - | -54.07%(-24.3%) |
| Dec 2020 | -71.34%(-72.4%) | -71.44%(-41.2%) |
| Sept 2020 | - | -121.49%(-48.3%) |
| June 2020 | - | -235.06%(+40.6%) |
| Mar 2020 | - | -167.22%(-25.5%) |
| Dec 2019 | -258.25%(+205.6%) | -224.36%(+42.6%) |
| Sept 2019 | - | -157.37%(+18.7%) |
| June 2019 | - | -132.58%(+40.2%) |
| Mar 2019 | - | -94.54%(+8.8%) |
| Dec 2018 | -84.50%(+27.4%) | -86.92%(+28.7%) |
| Sept 2018 | - | -67.56%(-6.8%) |
| June 2018 | - | -72.49%(-3.7%) |
| Mar 2018 | - | -75.30%(+12.3%) |
| Dec 2017 | -66.35%(+34.7%) | -67.08%(-4.4%) |
| Sept 2017 | - | -70.20%(+16.8%) |
| June 2017 | - | -60.10%(-3.9%) |
| Mar 2017 | - | -62.56%(+32.3%) |
| Dec 2016 | -49.27%(+142.6%) | -47.29%(+22.8%) |
| Sept 2016 | - | -38.52%(+74.1%) |
| June 2016 | - | -22.13%(+37.0%) |
| Mar 2016 | - | -16.15%(-15.3%) |
| Dec 2015 | -20.31%(-53.8%) | -19.07%(+44.5%) |
| Sept 2015 | - | -13.20%(-46.6%) |
| June 2015 | - | -24.73%(-19.6%) |
| Mar 2015 | - | -30.75%(-9.3%) |
| Dec 2014 | -43.93%(-70.8%) | -33.89%(-25.8%) |
| Sept 2014 | - | -45.66%(-46.7%) |
| June 2014 | - | -85.64%(-20.8%) |
| Mar 2014 | - | -108.15%(-27.9%) |
| Dec 2013 | -150.47%(+216.4%) | -150.02%(+16.2%) |
| Sept 2013 | - | -129.09%(+65.2%) |
| June 2013 | - | -78.16%(+41.3%) |
| Mar 2013 | - | -55.31%(+7.2%) |
| Dec 2012 | -47.56%(+48.1%) | -51.60%(-12.7%) |
| Sept 2012 | - | -59.14%(+22.1%) |
| June 2012 | - | -48.43%(+16.3%) |
| Mar 2012 | - | -41.65%(+42.1%) |
| Dec 2011 | -32.12% | -29.32%(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -30.46%(+24.5%) |
| June 2011 | - | -24.47%(-26.0%) |
| Mar 2011 | - | -33.06%(+1.8%) |
| Dec 2010 | -32.53%(-46.5%) | -32.49%(+1.7%) |
| Sept 2010 | - | -31.94%(-11.9%) |
| June 2010 | - | -36.27%(-24.4%) |
| Mar 2010 | - | -47.95%(-20.6%) |
| Dec 2009 | -60.81%(+17.6%) | -60.38%(-5.2%) |
| Sept 2009 | - | -63.72%(-25.4%) |
| June 2009 | - | -85.37%(+36.4%) |
| Mar 2009 | - | -62.60%(+18.1%) |
| Dec 2008 | -51.72%(+25.9%) | -53.00%(+38.1%) |
| Sept 2008 | - | -38.37%(+7.4%) |
| June 2008 | - | -35.71%(+2.8%) |
| Mar 2008 | - | -34.73%(-11.6%) |
| Dec 2007 | -41.09%(-21.8%) | -39.28%(-24.8%) |
| Sept 2007 | - | -52.25%(-14.8%) |
| June 2007 | - | -61.32%(-8.0%) |
| Mar 2007 | - | -66.63%(+11.3%) |
| Dec 2006 | -52.56%(-33.0%) | -59.84%(-9.7%) |
| Sept 2006 | - | -66.27%(+2.5%) |
| June 2006 | - | -64.64%(+6.6%) |
| Mar 2006 | - | -60.66%(-34.1%) |
| Dec 2005 | -78.40%(+9.3%) | -92.07%(-9.5%) |
| Sept 2005 | - | -101.68%(+10.9%) |
| June 2005 | - | -91.72%(-0.3%) |
| Mar 2005 | - | -92.04%(+47.0%) |
| Dec 2004 | -71.73%(+44.3%) | -62.61%(+13.4%) |
| Sept 2004 | - | -55.21%(-1.0%) |
| June 2004 | - | -55.75%(-20.6%) |
| Mar 2004 | - | -70.23%(+4.2%) |
| Dec 2003 | -49.70%(-63.8%) | -67.37%(-25.2%) |
| Sept 2003 | - | -90.07%(-2.8%) |
| June 2003 | - | -92.70%(+1.1%) |
| Mar 2003 | - | -91.67%(-23.1%) |
| Dec 2002 | -137.30%(+60.3%) | -119.28%(+11.8%) |
| Sept 2002 | - | -106.73%(-4.1%) |
| June 2002 | - | -111.29%(-13.2%) |
| Mar 2002 | - | -128.19%(+7.8%) |
| Dec 2001 | -85.63%(+4.9%) | - |
| Sept 2001 | - | -118.90%(+8.9%) |
| June 2001 | - | -109.18%(-15.2%) |
| Mar 2001 | - | -128.73%(+10.8%) |
| Mar 2001 | -81.64%(-14.4%) | - |
| Dec 2000 | - | -116.15%(+15.3%) |
| Sept 2000 | - | -100.73%(+10.6%) |
| June 2000 | - | -91.04%(+23.7%) |
| Mar 2000 | -95.37%(+19.9%) | -73.61%(-3.6%) |
| Dec 1999 | - | -76.36%(+43.5%) |
| Sept 1999 | - | -53.21%(+41.5%) |
| June 1999 | - | -37.60%(+124.5%) |
| Mar 1999 | -79.52% | -16.75%(-280.9%) |
| Dec 1998 | - | 9.26% |
FAQ
- What is Inovio Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual ROE year-on-year change?
- What is Inovio Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly ROE year-on-year change?
What is Inovio Pharmaceuticals annual return on equity?
The current annual ROE of INO is -79.55%
What is the all time high annual ROE for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual return on equity is -20.31%
What is Inovio Pharmaceuticals annual ROE year-on-year change?
Over the past year, INO annual return on equity has changed by +10.42% (+11.58%)
What is Inovio Pharmaceuticals quarterly return on equity?
The current quarterly ROE of INO is -118.17%
What is the all time high quarterly ROE for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly return on equity is 9.26%
What is Inovio Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, INO quarterly return on equity has changed by -35.53% (-42.99%)